Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum

Brain Research

Volumn 1483, Issue , 2012, Pages 31-38

  Yarosh, Haley L ^a   Angulo, Jesus A ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cyclic GMP; Methamphetamine; Neuropeptide Y; Nitric oxide; Striatum

Indexed keywords

3 NITROTYROSINE; CASPASE 3; CYCLIC GMP; MESSENGER RNA; METHAMPHETAMINE; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NITRIC OXIDE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL POPULATION; CEREBROSPINAL FLUID; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVATION; ENZYME LOCALIZATION; IMMUNOFLUORESCENCE; MALE; MOUSE; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; ANIMALS; ARGININE; CASPASE 3; CORPUS STRIATUM; CYCLIC GMP; DRUG INTERACTIONS; MALE; METHAMPHETAMINE; MICE; MICE, INBRED ICR; MICROINJECTIONS; NEUROPEPTIDE Y; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDES; PROTEIN PRECURSORS; RECEPTORS, NEUROPEPTIDE Y; RNA, MESSENGER; TYROSINE;

MURINAE;

EID: 84867582186     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.09.013     Document Type: Article

References (52)

1. T. Abekawa, T. Ohmori, and T. Koyama Effect of NO synthesis inhibition on striatal dopamine release and stereotyped behavior induced by a single administration of methamphetamine Prog. Neuropsychopharmacol. Biol. Psychiatry. 5 1997 831 838
2. T.E. Adrian, J.M. Allen, S.R. Bloom, M.A. Ghatei, M.N. Rossor, G.W. Roberts, T.J. Crow, K. Tatemoto, and J.M. Polak Neuropeptide Y distribution in human brain Nature 306 1983 584 586
3. M.A. Ariano, and A.I. Matus Ultrastructural localization of cyclic GMP and cyclic AMP in rat striatum J. Cell Biol. 91 1981 287 292
4. M.A. Ariano, J.A. Lewicki, H.J. Brandwein, and F. Murad Immunohistochemical localization of guanylate cyclase within neurons of rat brain Proc. Natl. Acad. Sci. USA 79 1982 1316 1320
5. M.A. Ariano, A.E. Grissell, F.C. Littlejohn, T.M. Buchanan, J.D. Elsworth, T.J. Collier, and K. Steece-Collier Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection neurons J. Neurosci. Res. 82 2005 387 396
6. L. Caberlotto, K. Fuxe, G. Sedvall, and Y.L. Hurd Localization of neuropeptide Y Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatum Eur. J. Neurosci. 9 1997 1212 1225
7. J. Caberlotto, K. Fuxe, J.M. Rimland, G. Sedvall, and Y.L. Hurd Regional distribution of neuropeptide Y Y2 receptor messenger RNA in the human post mortem brain Neuroscience 86 1998 167 178
8. J.L. Cadet, P. Sheng, S. Ali, R. Rothman, E. Carlson, and C. Epstein Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice J. Neurochem. 62 1994 380 383
9. J.L. Cadet, and C. Brannock Free radicals and the pathobiology of brain dopamine systems Neurochem. Int. 32 1998 117 131
10. V.L. Dawson, and T.M. Dawson Nitric oxide neurotoxicity J. Chem. Neuroanat. 10 1996 179 190
11. D.A. Di Monte, J.E. Royland, M.W. Jakowec, and J.W. Langston Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase J. Neurochem. 67 1996 2443 2450
12. C.J. Epstein, K.B. Avraham, M. Lovett, S. Smith, O. Elroy-Stein, G. Rotman, C. Bry, and Y. Groner Transgenic mice with increased CuZn-superoxide dismutase activity: animal model of dosage effects in Down syndrome Proc. Natl. Acad. Sci. USA 84 1987 8044 8048
13. H.C. Fibiger, and E.G. McGeer Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla Eur. J. Pharm. 16 1971 176 180
14. K.B.J. Franklin, and G. Paxinos The Mouse Brain in Stereotaxic Coordinates 1997 Academic Press San Diego
15. S. Furtinger, S. Pirker, T. Czech, C. Baumgartner, G. Ransmayr, and G. Sperk Plasticity of Y2 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy J. Neurosci. 21 2001 5804 5812
16. J. Garthwaite Concepts of neural nitric oxide-mediated transmission Eur. J. Neurosci. 27 2008 2783 2802
17. D.R. Gehlert, L.S. Beavers, D. Johnson, S.L. Gackenheimer, D.A. Schober, and R.A. Gadski Expression cloning of a human brain neuropeptide Y Y2 receptor Mol. Pharmacol. 49 1996 224 228
18. L. Grundemar, and R. Hakanson Neuropeptide Y effector systems: perspectives for drug development Trends Pharmacol. Sci. 15 1994 153 159
19. M. Heilig, C. Wahlestedt, R. Ekman, and E. Widerlov Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in rat brain Eur. J. Phamacol. 147 1988 465 467
20. M. Heilig, B. Soderpalm, J.A. Engel, and E. Widerlov Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models Psychopharmacol. (Berlin) 98 1989 524 529
21. H.H. Hirata, B. Ladenheim, E. Carlson, C. Epstein, and J.L. Cadet Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice Brain Res. 714 1996 95 103
22. K.A. Horner, S.C. Westwood, R.G. Hanson, and K.A. Keefe Multiple high doses of methamphetamine increase the number of preproneuropeptide Y mRNA-expressing neurons in the striatum of rat via a dopamine D1 receptor-dependent mechanism J. Pharmacol. Exp. Ther. 319 2006 414 421
23. A.J. Hotchkiss, M.E. Morgan, and J.W. Gibb The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities Life Sci. 25 1979 1373 1378
24. S.Z. Imam, G.D. Newport, Y. Itzhak, J.L. Cadet, F. Islam, W. Slikker Jr., and S.F. Ali Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase J. Neurochem. 76 2001 745 749
25. S.Z. Imam, and S.F. Ali Aging increases the susceptibility to methamphetamine-induced dopaminergic neurotoxicity in rats: correlation with peroxynitrite production and hyperthermia J. Neurochem. 78 2001 952 959
26. S.Z. Imam, G.D. Newport, Y. Itzhak, J.L. Cadet, F. Islam, W. Slikker Jr., and S.F. Ali Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase J. Neurochem. 76 2001 745 749
27. Y. Itzhak, and S.F. Ali The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo J. Neurochem. 67 1996 1770 1773
28. Y. Itzhak, C. Gandia, P.L. Huang, and S.F. Ali Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity J. Pharmacol. Exp. Ther. 284 1998 1040 1047
29. D. Jacques, Y. Tong, Y. Dumont, S.H. Shen, and R. Quirion Expression of the neuropeptide Y Y1 receptor mRNA in the human brain: an in situ hybridization study Neuroreport 7 1996 1053 1056
30. S. Jayanthi, X. Deng, P.A. Noailles, B. Ladenheim, and J.L. Cadet Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascade FASEB J. 18 2004 238 251
31. S.R. Jones, R.R. Gainetdinov, R.M. Wightman, and M.G. Caron Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter J. Neurosci. 18 1998 1979 1986
32. A. Kask, J. Harro, S. von Horsten, J.P. Redrobe, Y. Dumont, and R. Quirion The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y Neurosci. Biobehav. Rev. 26 2002 259 283
33. U.B. Kaupp, and R. Seifert Cyclic nucleotide-gated ion channels Physiol. Rev. 82 2002 769 824
34. Y. Kawaguchi, C.J. Wilson, S.J. Augood, and P.C. Emson Striatal interneurons - chemical, physiological and morphological characterization Trends Neurosci. 18 1995 527 535
35. Y. Kawaguchi Neostriatal cell subtypes and their functional roles Neurosci. Res. 27 1997 1 8
36. I. Krasnova, and J.L. Cadet Methamphetamine toxicity and messengers of death Brain Res. Rev. 60 2009 379 407
37. Y. Okahisa, H. Ujike, T. Kotaka, Y. Morita, M. Kodama, T. Inada, M. Yamada, N. Iwata, M. Iyo, I. Sora, N. Ozaki, and M. Kuroda Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence Psychiatry Clin. Neurosci. 63 2009 417 422
38. T. Pedrazzini, F. Pralong, and E. Grousmann Neuropeptide Y: the universal soldier Cell Mol. Life Sci. 60 2003 350 377
39. A.P. Silva, P.S. Pinheiro, A.P. Carvalho, C.M. Carvalho, B. Jakobsen, J. Zimmer, and J.O. Malva Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures FASEB J. 17 2003 1118 1120
40. A.P. Silva, S. Xapelli, E. Grouzmann, and C. Cavadas The putative neuroprotective role of neuropeptide Y in the central nervous system Curr. Drug Targets - CNS Neurol. Disord. 4 2005 331 347
41. S.E. Stephans, and B.K. Yamamoto Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux Synapse 17 1994 203 209
42. N. Thiriet, X. Deng, M. Solinas, B. Ladenheim, W. Curtis, S.R. Goldberg, R.D. Palmiter, and J.L. Cadet Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum J. Neurosci. 25 2005 5273 5279
43. A. Thorsell, R. Rimondini, and M. Heilig Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats Neurosci. Lett. 332 2002 1 4
44. United Nations Office on Drugs and Crime World Drug Report 2011 United Nations Publication Vienna, Austria p. 127
45. J. Wang, W. Xu, S.F. Ali, and J.A. Angulo Connection between the striatal neurokinin-1 receptor and nitric oxide formation during methamphetamine exposure Ann. N. Y. Acad. Sci. 1139 2008 164 171
46. J. Wang, and J.A. Angulo Synergism between methamphetamine and the neuropeptide substance P on the production of nitric oxide in the striatum of mice Brain Res. 1369 2011 131 139
47. S.C. Westwood, and G.R. Hanson Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems J. Pharmacol. Exp. Ther. 288 1999 1160 1166
48. V. Wykes, T.C. Bellamy, and J. Garthwaite Kinetics of nitric oxide-cyclic GMP signaling in CNS cells and its possible regulation by cyclic GMP J. Neurochem. 83 2002 37 47
49. E. Zambello, L. Zanetti, G.F. Hedou, O. Angelici, R. Arban, R.O. Tasan, G. Sperk, and L. Caberlotto Neuropeptide Y-Y2 receptor knockout mice: influence of genetic background on anxiety-related behaviors Neuroscience 176 2011 420 430
50. J.P.Q. Zhu, W. Xu, and J.A. Angulo Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice Brain Res. 1049 2005 171 181
51. J. Zhu, W. Xu, and J.A. Angulo Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice Neuroscience 140 2006 607 622
52. J.P.Q. Zhu, W. Xu, J. Wang, S.F. Ali, and J.A. Angulo The neurokinin-1 receptor modulates the methamphetamine-induced striatal apoptosis and nitric oxide formation in mice J. Neurochem. 111 2009 656 668